EDITOR'S NOTE
U.S. stocks saw a mixed trading session Tuesday as developments with the Covid omicron variant continued to influence market leadership.
The Dow Jones Industrial Average notched its fifth straight winning day, adding 95.83 points. Meanwhile, the S&P 500 closed 0.1% lower after setting a new intraday record early in the session. The Nasdaq Composite also struggled, slipping 0.5%.
The Centers for Disease Control and Prevention on Monday shortened its guidelines on isolation for asymptomatic people who test positive to five days from 10. Research also indicated that omicron infections can help boost immunity to the earlier delta strain of Covid.
Travel-related stocks hit hard from negative Covid headlines on Monday rebounded Tuesday with Boeing among the top gainers on the Dow. Airline stocks also closed higher. 
Meanwhile, the chip stocks that boosted the S&P 500 and the Nasdaq Composite Monday turned lower Tuesday. Names like Nvidia and Applied Materials pulled back and weighed on those indexes. Covid drug makers Pfizer and Moderna also dropped.
The S&P 500 is now up more than 27% on the year as investors look to close out 2021, but some Wall Street pros predict relatively small gains for stocks in 2022 after two strong years.
“Heading into next year, we do think that growth is going to come down a little bit, but it's still going to be pretty decent growth,” said Victoria Fernandez, chief market strategist at Crossmark Global Investments.
TOP NEWS
TOP VIDEO
CNBC PRO
SPECIAL REPORTS
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
